June 2026
The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.
June 2026
The global THR-β agonist market size was evaluated at USD 1.53 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 15.72%.
February 2026
The global GnRH receptor antagonists market size was evaluated at USD 2.32 billion in 2025 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 8.50%.